Madrigal Pharmaceuticals, Inc. (MDGL) has a market capitalization of $12.04B and trades at $524.99. The 52-week range is 265-615.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -40.9, Earnings Per Share (EPS) of $-12.85, annual revenue of $958.4M.
The stock has a beta of -1.01, operates in the Healthcare sector.
